[Pharmacological and toxicological characterization of a multicomponent preparation in the treatment of circulatory disorders].
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000470:Alkaloids / Q000633:toxicity; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004878:Ergotamine / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects; D013045:Species Specificity; D014599:Uterus / Q000187:drug effects
D000470:Alkaloids; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists; D009538:Nicotine; D010424:Pentobarbital; D004878:Ergotamine; D009638:Norepinephrine; D004837:Epinephrine
Pharmakologisch-toxikologische Charakterisierung eines Mehrkomponentenpräparates zur Therapie von Durchblutungsstörungen.